Yukie Yoshii
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
First-in-human phase I study of hypoxia-targeting 64Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64).
Journal: ESMO open
Published: January 04, 2026
Local therapy with hypoxia-targeting radiopharmaceutical [64Cu]Cu-ATSM in high-grade glioma patient-derived xenograft models.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: September 15, 2025
Digital FDG-PET Detects MYD88 Mutation-Driven Glycolysis in Primary CNS Lymphoma.
Journal: AJNR. American journal of neuroradiology
Published: March 19, 2025
[Measurement of Airborne Radioactivity in the Inpatient Room after Administering [64Cu]Cu-ATSM to Patients].
Journal: Kaku igaku. The Japanese journal of nuclear medicine
Published: January 29, 2025
Long-Term Therapeutic Effects of 225Ac-DOTA-E[c(RGDfK)]2 Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma.
Journal: Pharmaceutics
Published: November 29, 2024
Efficacy of radioactive hypoxia-targeting therapeutic agent 64Cu-ATSM on recurrent malignant glioma: a study protocol for a phase-III, investigator-sponsored, randomized controlled trial.
Journal: Japanese journal of clinical oncology
Published: October 10, 2024
Preclinical evaluation of 64Cu-labeled cetuximab in immuno-PET for detecting sentinel lymph node metastasis in epidermal growth factor receptor-positive breast cancer.
Journal: Breast cancer research : BCR
Published: August 14, 2024
64Cu2+ Complexes of Tripodal Amine Ligands' In Vivo Tumor and Liver Uptakes and Intracellular Cu Distribution in the Extrahepatic Bile Duct Carcinoma Cell Line TFK-1: A Basic Comparative Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 29, 2024
Trace Metal Impurities Effects on the Formation of [64Cu]Cu-diacetyl-bis(N4-methylthiosemicarbazone) ([64Cu]Cu-ATSM).
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 15, 2023
An In Vivo Dual-Observation Method to Monitor Tumor Mass and Tumor-Surface Blood Vessels for Developing Anti-Angiogenesis Agents against Submillimeter Tumors.
Journal: International journal of molecular sciences
Published: October 04, 2023
Process to Remove the Size Variants Contained in the Antibody-Chelator Complex PCTA-NCAB001 for Radiolabeling with Copper-64.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 22, 2023
Last Updated: 09/26/2026